We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

167 hedge funds and large institutions have $2.77B invested in Arcellx in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 80 increasing their positions, 49 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $5.29M | Put options by funds: $3.07M

63% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 49

33% more funds holding in top 10

Funds holding in top 10: 912 (+3)

4.84% more ownership

Funds ownership: 89.08%93.92% (+4.8%)

9% less funds holding

Funds holding: 183167 (-16)

15% less capital invested

Capital invested by funds: $3.27B → $2.77B (-$497M)

41% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 37

Holders
167
Holders Change
-16
Holders Change %
-8.74%
% of All Funds
2.41%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.17%
New
22
Increased
80
Reduced
49
Closed
37
Calls
$5.29M
Puts
$3.07M
Net Calls
+$2.22M
Net Calls Change
+$9.76M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$17.3M +$1.73M +31,883 +11%
PHS
27
PFM Health Sciences
California
$17.2M +$477K +8,770 +3%
UBS AM
28
UBS AM
Illinois
$17.1M +$2.44M +44,972 +17%
Bank of America
29
Bank of America
North Carolina
$16.7M -$6.04M -111,135 -27%
Victory Capital Management
30
Victory Capital Management
Texas
$15.7M +$2.61M +48,006 +20%
SC
31
Stempoint Capital
New York
$15.5M +$7.63M +140,442 +100%
IHAM
32
Integral Health Asset Management
New York
$15.2M +$1.09M +20,000 +8%
JP Morgan Chase
33
JP Morgan Chase
New York
$14.4M -$15.8M -290,391 -53%
Goldman Sachs
34
Goldman Sachs
New York
$14.2M -$795K -14,626 -5%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$13M +$2.18M +40,154 +21%
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$13M -$6.98M -128,365 -35%
VOYA Investment Management
37
VOYA Investment Management
Georgia
$12M -$8.93M -164,271 -43%
CS
38
Candriam SCA
Luxembourg
$12M -$163K -3,000 -1%
CCM
39
Cutter Capital Management
New York
$10.3M +$4.35M +80,000 +75%
EAM
40
Eagle Asset Management
Florida
$10.2M -$1.84M -33,930 -15%
SCM
41
Soleus Capital Management
Connecticut
$9.42M +$1.13M +20,741 +14%
PHP
42
Parkman Healthcare Partners
Connecticut
$8.66M +$13.3K +245 +0.2%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$8.12M +$1.42M +26,134 +22%
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$7.98M +$2.36M +43,450 +43%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$6.79M +$1.8M +33,200 +37%
N
46
Nuveen
North Carolina
$6.73M -$3.53M -64,872 -35%
WP
47
Woodline Partners
California
$5.94M +$198K +3,639 +3%
Man Group
48
Man Group
United Kingdom
$5.74M +$5.66M +104,046 New
Rafferty Asset Management
49
Rafferty Asset Management
New York
$4.74M -$2.23M -40,939 -32%
DFO
50
Duquesne Family Office
New York
$4.09M

ACLX Hedge Fund Activity: Q2 2024 in Review

167 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q2 2024, worth a combined $2.77B — down 15% from $3.27B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of ACLX and 22 opened new positions — a net loss of 15 holders — while 49 trimmed existing stakes and 80 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $87.2M. The largest seller was Lord, Abbett & Co, cutting an estimated $17.6M.

  • 167 institutional investors held Arcellx (ACLX) as of Q2 2024, down from 183 in Q1 2024.
  • Funds reported $2.77B of Arcellx stock for Q2 2024, down 15% quarter-over-quarter.
  • 22 funds opened new Arcellx positions in Q2 2024 and 37 closed out, a net change of -15 holders.
  • The largest Arcellx buyer in Q2 2024 was RA Capital Management, an estimated $87.2M added.
  • The largest Arcellx seller in Q2 2024 was Lord, Abbett & Co, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2024.